Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
Conditions: Breast Cancer; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma Interventions: Drug: AB-201; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: GC Cell Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Gastric (Stomach) Cancer | Gastroenterology | Research